Archive: 25/04/2012

Research shows how PCBs promote dendrite growth, may increase autism risk

New research from UC Davis and Washington State University shows that PCBs, or polychlorinated biphenyls, launch a cellular chain of events that leads to an overabundance of dendrites — the filament-like projections ...

Apr 25, 2012

Small 'neural focus groups' predict anti-smoking ad success

Brain scans of a small group of people can predict the actions of entire populations, according to a new study by researchers from the University of Michigan, the University of Oregon and the University of California at Los ...

Apr 25, 2012

0

0

Malaria bed net strategies will save global community estimated $600 million over the next 5 years

The universal coverage campaign for bed nets succeeded in dramatically extending access to these life-saving products, though recent gains may be in jeopardy unless rapid action is taken. Over 560 million long-lasting insecticide-treated ...

Apr 25, 2012

Protecting your brain: 'Use it or lose it'

The findings of a new study suggest that the protective effects of an active cognitive lifestyle arise through multiple biological pathways.

Apr 25, 2012

Risk of future emotional problems can be identified during well-child visits

A new study suggests clinicians might be able to identify children at risk of later emotional or behavioral problems by paying attention to a few key signs during early well-child check-ups. Researchers found that boys ...

Apr 25, 2012

0

0

TV ads entice kids to drink alcohol: study

(Medical Xpress) -- Efforts to reduce alcohol-related harm in Australia are being frustrated by high levels of alcohol advertising on television, particularly at times when children are likely to be watching, according to ...

Apr 25, 2012

0

0

Vitamin D deficiency shown to increase rejection rates in lung transplant patients

(Medical Xpress) -- Vitamin D deficiency is associated with an increase in lung transplant rejection and infections, according to research conducted at Loyola University Health System (LUHS). Researchers also found that recipients ...

Apr 25, 2012

EU approves Novartis drug Signifor for Cushing's disease

European Union regulators have given Swiss pharmaceutical group Novartis a green light to market its drug Signifor as a treatment for Cushing's disease, the company said Wednesday.

Apr 25, 2012